首頁 > 市場調查報告書 > 醫療設備

手術用器具泌尿科

市場調查報告書

商品編碼

1560817

全球碎石機設備市場 - 2024 - 2031

Global Lithotripter Devices Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球碎石機設備市場在 2023 年達到 11.5 億美元，預計到 2031 年將達到 18.7 億美元，2024-2031 年預測期間複合年成長率為 6.3%。

碎石機是一種用於治療腎結石和泌尿道內其他結石（結石）的醫療設備。它的工作原理是產生衝擊波，將結石破碎成更小的碎片，使它們更容易透過排尿排出。碎石機的主要類型包括體外震波碎石（ESWL）裝置和體內碎石裝置。

ESWL 設備在體外產生衝擊波，利用 X光或超音波等成像技術將衝擊波定向到結石的位置。衝擊波穿透身體並碎石，無需手術干預。 ESWL 被認為是治療腎結石最常見且侵入性最小的方法。

體內碎石裝置直接插入體內以碎石。他們利用各種能源，包括雷射、電動液壓、機械或超音波能量來破碎石頭。當 ESWL 不適合時，例如涉及輸尿管結石或難以通過 ESWL 碎裂的結石時，通常會使用體內碎石術。

市場動態：

司機

尿路結石發生率增加及技術進步

全球碎石設備市場的需求是由多種因素所驅動的。主要因素之一是尿路結石發生率的增加和技術的進步。腎結石和相關尿路結石盛行率的上升是碎石設備需求的主要驅動力。碎石技術的持續創新正在顯著提高治療效果並推動市場成長。

這些進步的重點是開發更有效、更安全的設備，以解決臨床療效和病人安全問題。突發波碎石術 (BWL) 和高頻衝擊波等創新代表了腎結石治療的重大進步，提高了碎石的有效性和手術的安全性。

此外，該行業的主要參與者產品發布和關鍵開發將推動該市場的成長。例如，2024 年 5 月，多尼爾醫療科技推出了 UroGPT，這是第一個專門用於幫助患者處理腎結石的人工智慧工具。這項創新應用程式旨在透過提供與腎結石管理相關的可靠、按需資訊和可行的見解來加強患者護理。

此外，波士頓科學公司還計劃於 2024 年 3 月透過其採用先進 MOSES 2.0 技術的 Lumenis Pulse 120H 钬雷射系統支援韓國的腎結石治療。該系統旨在提高碎石術的效率和效果，這對於治療尿路結石症或腎結石至關重要。

限制

替代治療方案的可用性以及碎石設備相關的不良反應等因素預計將阻礙市場。

細分市場分析

全球碎石設備市場根據類型、應用、最終用戶和地區進行細分。

體外震波碎石設備 (ESWL) 領域約佔全球碎石設備市場佔有率的 72%

體外震波碎石設備（ESWL）領域預計將在預測期內佔據最大的市場佔有率。體外震波碎石術（ESWL）是一種非侵入性醫療技術，主要用於治療腎結石。此手術使用衝擊波將結石破碎成小塊，使它們更容易通過尿道。 ESWL 因其有效性和與傳統手術方法相比可縮短恢復時間而成為首選。

此外，政府的舉措和支持、金融投資和關鍵發展將推動該市場的成長。例如，2023 年 6 月，Barking、Havering 和 Redbridge University Hospitals NHS Trust 旗下的喬治國王醫院在減少泌尿科擇期手術積壓方面面臨挑戰。為了解決這個問題，該醫院投資了一台新的體外震波碎石機（ESWL），以更有效地治療腎結石患者。

同樣，2023 年 5 月，衛生部長馬雲。 Subramanian 在政府 Kilpauk 醫學院 (KMC) 醫院開設了體外震波碎石術 (ESWL) 治療中心。這台 ESWL 機器由摩比斯印度基金會透過其企業社會責任計畫資助，耗資 23 億盧比。

市場地域佔有率

北美約佔全球碎石設備市場佔有率的44.6%

由於腎結石發病率的增加是推動北美碎石設備市場的主要因素，預計北美地區將在預測期內佔據最大的市場佔有率。這種不斷上升的盛行率對有效的治療解決方案產生了更大的需求，例如碎石術，它因其非侵入性的腎結石治療方法而受到青睞。

患者偏好轉向微創和非侵入性手術是現代醫療保健的重要趨勢，特別是在腎結石碎石術方面。碎石技術的不斷進步，特別是更有效率、更安全的設備的創造，正在改善治療效果。突發波碎石術和高頻衝擊波等創新技術可以更準確地定位腎結石，從而降低鄰近組織受損的風險。

此外，大量關鍵參與者的存在、先進的醫療基礎設施、產品發布和批准以及政府措施有助於推動該市場的成長。例如，2024 年 3 月，Calyxo Inc. 重新設計的 CVAC（連續真空抽吸導管）系統獲得 FDA 批准，該系統專門用於在雷射碎石手術後收集腎結石碎片。這種創新設備旨在透過最大限度地減少可能導致併發症的殘餘結石負擔來提高腎結石治療的有效性。

同樣，2024年5月，Huons Meditech在德克薩斯州舉行的美國泌尿外科協會（AUA）2024年會議上展示了其電磁衝擊波碎石機ASADAL-M1。該活動是全球最負盛名的泌尿外科會議之一，吸引了領先的泌尿科醫生和醫療保健專業人士討論該領域的創新和進步。

A lithotripter is a medical device utilized for the treatment of kidney stones and other calculi (stones) within the urinary tract. It operates by generating shock waves that break the stones into smaller fragments, allowing them to be more easily expelled through urination. The primary types of lithotripters include extracorporeal shock wave lithotripsy (ESWL) devices and intracorporeal lithotripsy devices.

ESWL devices produce shock waves outside the body, which are directed at the location of the stones using imaging techniques such as X-ray or ultrasound. The shock waves penetrate the body and fragment the stones without the need for surgical intervention. ESWL is recognized as the most common and least invasive method for treating kidney stones.

Intracorporeal lithotripsy devices are inserted directly into the body to break up stones. They employ various energy sources, including laser, electrohydraulic, mechanical, or ultrasonic energy, to fragment the stones. Intracorporeal lithotripsy is typically used when ESWL is not suitable, such as in cases involving stones located in the ureter or those that resist fragmentation through ESWL.

Market Dynamics: Drivers

Increasing incidence of urolithiasis and technological advancements

The demand for the global lithotripter devices market is driven by multiple factors. One of the primary factors is the increasing incidence of urolithiasis and technological advancements. The rising prevalence of kidney stones and related urolithiasis conditions is a primary driver for the demand for lithotripsy devices. Continuous innovations in lithotripsy technology are significantly enhancing treatment outcomes and driving market growth.

These advancements focus on developing more effective and safer devices, that address both clinical efficacy and patient safety. Innovations such as burst wave lithotripsy (BWL) and high-frequency shock waves represent significant advancements in the treatment of kidney stones, enhancing both the effectiveness of stone fragmentation and the safety of the procedure.

Moreover, key players in the industry product launches and key developments that would propel this market growth. For instance, in May 2024, Dornier MedTech launched UroGPT, the first artificial intelligence tool specifically designed to assist patients dealing with kidney stones. This innovative application aims to enhance patient care by providing reliable, on-demand information and actionable insights related to kidney stone management.

Also, in March 2024, Boston Scientific is set to support kidney stone treatment in South Korea with its Lumenis Pulse 120H Holmium Laser System, which incorporates the advanced MOSES 2.0 technology. This system is designed to enhance the efficiency and effectiveness of lithotripsy procedures, which are critical for managing urolithiasis, or kidney stones.

Restraints

Factors such as the availability of alternative treatment options, and adverse effects associated with lithotripsy devices are expected to hamper the market.

Market Segment Analysis

The global lithotripter devices market is segmented based on type, application, end-user, and region.

The extracorporeal shock wave lithotripsy devices (ESWL) segment accounted for approximately 72% of the global lithotripter devices market share

The extracorporeal shock wave lithotripsy devices (ESWL) segment is expected to hold the largest market share over the forecast period. Extracorporeal Shock Wave Lithotripsy (ESWL) is a non-invasive medical technique primarily utilized for the treatment of kidney stones. This procedure uses shock waves to fragment the stones into smaller pieces, making it easier for them to be passed through the urinary tract. ESWL is preferred due to its effectiveness and the reduced recovery time it offers in comparison to conventional surgical methods.

Moreover, government initiatives & support, financial investments, and key developments would propel this market growth. For instance, in June 2023, King George Hospital, part of Barking, Havering, and Redbridge University Hospitals NHS Trust, faced challenges in reducing the elective surgery backlog in its urology department. To address this, the hospital invested in a new Extracorporeal Shock Wave Lithotripsy (ESWL) machine to treat patients with kidney stones more efficiently.

Similarly, in May 2023, Health Minister Ma. Subramanian inaugurated an Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment Centre at the Government Kilpauk Medical College (KMC) Hospital. The ESWL machine, which was funded by the MOBIS India Foundation through its corporate social responsibility initiatives, costs ₹2.3 crore.

Market Geographical Share

North America accounted for approximately 44.6% of the global lithotripter devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing occurrence of kidney stones is a major factor driving the lithotripsy device market in North America. This rising prevalence creates a greater need for effective treatment solutions, such as lithotripsy, which is favored for its non-invasive approach to managing kidney stones.

The shift in patient preference towards minimally invasive and non-invasive procedures is a significant trend in modern healthcare, particularly in the context of lithotripsy for kidney stones. Ongoing advancements in lithotripsy technology, particularly the creation of more efficient and safer devices, are improving treatment results. Innovations like burst wave lithotripsy and high-frequency shock waves enable more accurate targeting of kidney stones, reducing the risk of damage to adjacent tissues.

Moreover, a major number of key players' presence, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives help to drive this market growth. For instance, in March 2024, Calyxo Inc. received FDA approval for its redesigned CVAC (Continuous Vacuum Aspiration Catheter) system, which is specifically designed to collect kidney stone fragments following laser lithotripsy procedures. This innovative device aims to enhance the effectiveness of kidney stone treatments by minimizing the residual stone burden that can lead to complications.

Similarly, in May 2024, Huons Meditech showcased its electromagnetic shock wave lithotripter, the ASADAL-M1, at the American Urological Association (AUA) 2024 Conference held in Texas. This event is one of the most prestigious urological conferences globally, attracting leading urologists and healthcare professionals to discuss innovations and advancements in the field.

Market Segmentation

By Type

Extracorporeal Shock Wave Lithotripsy Devices (ESWL)

Intracorporeal Lithotripsy Devices

Mechanical Lithotripsy

Electrohydraulic Lithotripsy (EHL)

Laser Lithotripsy

Ultrasonic Lithotripsy

By Application

Kidney Stones

Ureteral Stones

Pancreatic Stones

Bile Duct Stones

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the lithotripter devices market include Boston Scientific Corporation, EDAP TMS, Richard Wolf GmbH, Olympus, Cook, Dornier MedTech., DirexGroup, STORZ MEDICAL AG, KARL STORZ, and ELMED Medical Systems among others

Key Developments

In February 2023, Rhein Laser introduced the UroFiber 150Q system, a cutting-edge SuperPulsed thulium fiber laser (TFL) technology designed to enhance treatments for stone lithotripsy and benign prostatic hyperplasia (BPH) enucleation. This system is notable for being the world's first 150W SuperPulsed TFL system, which allows for more effective and efficient procedures in urology.

Why Purchase the Report?

To visualize the global lithotripter devices market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points on the lithotripter devices market in all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global lithotripter devices market report would provide approximately 62 tables, 52 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Incidence of Urolithiasis and Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Availability of Alternative Treatment Options
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Extracorporeal Shock Wave Lithotripsy Devices (ESWL) *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intracorporeal Lithotripsy Devices
- 6.3.1. Mechanical Lithotripsy
- 6.3.2. Electrohydraulic Lithotripsy (EHL)
- 6.3.3. Laser Lithotripsy
- 6.3.4. Ultrasonic Lithotripsy

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Kidney Stones *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ureteral Stones
7.4. Pancreatic Stones
7.5. Bile Duct Stones

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Boston Scientific Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. EDAP TMS
11.3. Richard Wolf GmbH
11.4. Olympus
11.5. Cook
11.6. Dornier MedTech.
11.7. DirexGroup
11.8. STORZ MEDICAL AG,
11.9. KARL STORZ
11.10. ELMED Medical Systems. (*LIST NOT EXHAUSTIVE)